| Code |
Title |
|
–
|
Top Categories
|
|
3 |
Administration
|
|
3E |
Physiological Systems and Anatomical Regions
|
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
|
3E09 |
Nose
|
|
3E093 |
Percutaneous
|
|
3E0930 |
Antineoplastic
|
|
3E09305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Nose, Percutaneous Approach
|
|
3E0930M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach
|
|
3E0932 |
Anti-infective
|
|
3E09328
|
Oxazolidinones
Introduction of Oxazolidinones into Nose, Percutaneous Approach
|
|
3E09329
|
Other Anti-infective
Introduction of Other Anti-infective into Nose, Percutaneous Approach
|
|
3E0933 |
Anti-inflammatory
|
|
3E0933Z
|
No Qualifier
Introduction of Anti-inflammatory into Nose, Percutaneous Approach
|
|
3E0934 |
Serum, Toxoid and Vaccine
|
|
3E0934Z
|
No Qualifier
Introduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach
|
|
3E093B |
Anesthetic Agent
|
|
3E093BZ
|
No Qualifier
Introduction of Anesthetic Agent into Nose, Percutaneous Approach
|
|
3E093G |
Other Therapeutic Substance
|
|
3E093GC
|
Other Substance
Introduction of Other Therapeutic Substance into Nose, Percutaneous Approach
|
|
3E093H |
Radioactive Substance
|
|
3E093HZ
|
No Qualifier
Introduction of Radioactive Substance into Nose, Percutaneous Approach
|
|
3E093K |
Other Diagnostic Substance
|
|
3E093KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Nose, Percutaneous Approach
|
|
3E093N |
Analgesics, Hypnotics, Sedatives
|
|
3E093NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach
|
|
3E093T |
Destructive Agent
|
|
3E093TZ
|
No Qualifier
Introduction of Destructive Agent into Nose, Percutaneous Approach
|